Sodium-Glucose Cotransporter-2 Inhibitors and Euglycemic Diabetic Ketoacidosis: A Case Series of Three Post-surgical Patients
Abstract
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of commonly prescribed medications used in diabetes management for both their cardiovascular and renal benefits. However, as a class, SGLT2 inhibitors have a known side effect risk for ketoacidosis, including the rarer version called euglycemic diabetic ketoacidosis (DKA). We present three cases of euglycemic DKA postoperatively, in patients who were on SGLT2 inhibitors for type 2 diabetes mellitus. A DKA protocol was initiated for all three patients, and after treatment with fluid and insulin therapy, all patients recovered. All three were restarted on their SGLT2 inhibitor upon discharge. Based on this limited experience, we recommend close monitoring of postoperative patients on SGLT2 inhibitors to allow early detection of euglycemic DKA. Larger trials are needed to determine the exact, optimal timing of restarting SGLT2 inhibitors postoperatively.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.